Clearbridge Health Limited (1H3.SI stock) plunged 50.0% to S$0.001 in after hours trading on 10 Mar 2026 on the SES. The drop followed thin intraday liquidity with volume 3,000,000.00 shares and a previous close at S$0.002. Investors should note the tiny market cap of S$4,295,821.00 and the wide gap to the 50-day average price of S$0.00198. This piece explains the move, valuation metrics, a Meyka AI grade, and model forecasts to help frame the risks.
1H3.SI stock: after-hours drop and trading facts
The immediate fact: Clearbridge Health (1H3.SI) fell 50.0% to S$0.001 after hours on 10 Mar 2026. Trading volume was 3,000,000.00 shares versus an average volume of 4,437,086.00 shares, showing lower-than-average liquidity. The day range was fixed at S$0.001 and the stock sits at its year low of S$0.001. This price move magnifies volatility and makes intraday execution and spreads a material trading risk for small holders.
Valuation and near-term fundamentals
Clearbridge Health’s market cap is S$4,295,821.00 with 4,295,820,825.00 shares outstanding. Price-to-book is low at 0.13 and price-to-sales is 0.58, reflecting depressed equity value versus book. The company reports negative profitability: net income per share TTM is -0.00130 and ROE is -19.95%. These metrics explain why analysts rate it cautiously and why the stock reacts sharply to limited news or blocks of selling.
Meyka AI rates 1H3.SI with a score out of 100
Meyka AI rates 1H3.SI with a score out of 100: 61.72 / 100, Grade B, Suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. The proprietary score highlights reasonable balance-sheet metrics but weak profitability and liquidity risks. Grades are informational and not investment advice.
Meyka AI’s forecast model projects price paths
Meyka AI’s forecast model projects a 1-year price of S$0.005, a 3-year price of S$0.012, and a 5-year price of S$0.018. From the current S$0.001, the model implies a 1-year upside of 400.00% to S$0.005. Forecasts are model-based projections and not guarantees. There is no published analyst consensus price target for 1H3.SI, so model outputs should be used cautiously.
Technical setup and trading signals
Technically, the stock shows oversold readings: RSI 34.85 and CCI -165.93. Momentum indicators show a -50.00% ROC and an ADX of 68.08, indicating a strong trend. The 50-day average price sits at S$0.00198 and 200-day average at S$0.00254, both above the current price. Low price and near-zero ATR make standard technical overlays unreliable; traders should rely on volume and order book depth.
Sector context and comparable peers
Clearbridge operates in Healthcare, Medical – Diagnostics & Research. The Singapore healthcare sector has fallen 8.32% yesterday and shows weak YTD performance of -11.12%. Peer multiples in the sector are higher; the sector average PB is 1.62 versus Clearbridge at 0.13. This gap signals either deep undervaluation or company-specific operational issues that justify a discount.
Final Thoughts
Key takeaways: 1H3.SI stock plunged 50.0% after hours to S$0.001 on 10 Mar 2026, trading 3,000,000.00 shares and remaining at the year low. Fundamental ratios show negative profitability and low market valuation with PB 0.13 and price-to-sales 0.58. Meyka AI rates 1H3.SI at 61.72 out of 100 (Grade B, HOLD) while its forecast model projects S$0.005 in one year, implying a 400.00% upside from the current price. That forecast contrasts with weak cash flow metrics and near-term liquidity risk. For traders focused on top losers, 1H3.SI offers high upside in model outputs but comes with high execution risk, limited liquidity, and no recent analyst price targets. Use tight position sizing and verify company announcements before acting. Sources: Clearbridge Health website and company data image.
FAQs
Why did 1H3.SI stock drop 50% in after hours on 10 Mar 2026?
The 50% fall reflects thin liquidity and a low float on the SES, with 3,000,000.00 shares traded and no offsetting buy interest. Company-specific weak profitability and sector weakness amplified the move.
What valuation metrics should investors watch for 1H3.SI stock?
Watch price-to-book 0.13, price-to-sales 0.58, ROE -19.95%, and cash per share 0.00060. These show low market valuation but negative profitability and limited cash cushion.
Does Meyka AI provide a price target or forecast for 1H3.SI stock?
Yes. Meyka AI’s forecast model projects S$0.005 in one year and S$0.012 in three years. These are model projections and not guarantees; treat them as scenario inputs, not recommendations.
Is 1H3.SI stock a buy after this drop?
Meyka AI gives a Grade B and a HOLD suggestion. The stock shows high volatility, poor profitability, and liquidity risk. Only investors comfortable with those risks and small position sizes should consider it.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
What brings you to Meyka?
Pick what interests you most and we will get you started.
I'm here to read news
Find more articles like this one
I'm here to research stocks
Ask our AI about any stock
I'm here to track my Portfolio
Get daily updates and alerts (coming March 2026)